News

Come this spring adults won’t be the only ones with their own line of Fitbit trackers.

Gothenburg, Sweden-based Visiba Care announced that it has secured $3.

Fitbit has just announced its latest set of fitness wearables, alongside which will come a new platform that lets women track their menstrual and ovulation cycles.

Medtronic has finally received FDA clearance for Guardian Connect, its smartphone-connected standalone CGM for patients who use multiple daily injections (MDI) for their insulin.

Digital therapeutics may be up and coming, but they also have a long way to go before their mainstream treatment options, according to experts who spoke at the digital therapeutics deep dive at HIMSS18.

A team of researchers at Michigan State University have developed a smartphone-based blood pressure monitoring system that could be an alternative to the traditional blood pressure cuffs.

Duke University has launched a new Apple ResearchKit study, the MS Mosaic Study, aimed at using big data and patient insights to improve medical understanding of multiple sclerosis.

A new study, sponsored by the US Department of Veterans Affairs, applied wearable biosensors to post-acute heart failure patients and deployed FDA-cleared analytics from vendor physIQ to detect vital sign anomalies.

Worldwide there are 422 million people living with diabetes, according to World Health Organization estimates.

Over the weekend AliveCor announced that its technology was validated in two studies.